24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825

Medical Disorders
Resources
Basic InformationLookupsLatest News
Two Lives Saved in Rare 'Paired' Liver DonationYour Life Span May Be Foretold in Your Heart BeatsHealth Tip: Stopping NosebleedsKids Can Get UTIs, TooIs a New Remedy for Body Odor on the Horizon?Why More Patients Are Surviving an AneurysmCommon Diabetes Drug May Also Shield Kidneys, HeartIsraeli Team Announces First 3D-Printed Heart Using Human Cells'Added Sugars' Label on Foods Could Save Many LivesCPAP Brings Longer Life for Obese People With Sleep Apnea: StudyYoung Athletes Need to Be Sidelined After Bout of MonoPre-Cut Melons at Kroger, Walmart, Other Stores May Carry SalmonellaCDC Says Ground Beef Is Source of E. coli Outbreak, Cases Rise to 109AHA News: Is Yoga Heart-Healthy? It's No Stretch to See Benefits, Science SuggestsFDA Orders Label Warning on Alcohol Use With 'Female Viagra'Could Treating Gut Bacteria Help Ease Autism Symptoms?Hospital Privacy Curtains Could Be Breeding Ground for GermsItchy Skin Common Alongside Kidney DiseaseMany Misdiagnosed With MSVehicle Exhaust Drives Millions of New Asthma Cases AnnuallyNFL Retirees Help Scientists Develop Early Test for Brain Condition CTEMigraine Pain Linked to Raised Suicide RiskMore Time Spent in Sports, Faster Healing From ConcussionHealth Tip: Thermometer OptionsStill No Source as E. Coli Outbreak Grows to 96 Cases Across 5 States: CDCClimate Change Could Worsen Sneezin' SeasonEvenity Approved for Osteoporotic WomenNYC Declares Public Health Emergency Over Brooklyn Measles OutbreakInsurers' Denials of Opioid Coverage Spurs CDC to Clarify GuidelinesImmune-Targeted Treatment Might Help Prevent Peanut Allergy CrisesCluster of Dangerous Antibiotic-Resistant E. Coli Infection Spotted in NYCHealth Tip: Managing Chronic MigrainesFor One Man, Too Much Vitamin D Was DisastrousCDC Investigates Mystery E. Coli Outbreak Affecting 5 StatesBlacks Live Longer, Not Necessarily Better, With ALSIs It Heartburn or Something Else?Lungs, Hearts Infected With Hepatitis C Still OK for TransplantUnhealthy Diets May Be World's Biggest KillerSevere 'Mono' Infection May Raise Risk for Chronic Fatigue SyndromeUnder-the-Tongue Allergy Pills Replacing Shots for ManyFish Slime Could Hold Key to Beating 'Superbug' InfectionsPet Hedgehogs Still Spreading Salmonella, CDC WarnsCimzia Approved for Inflammatory ArthritisSpring Is the Sneezing SeasonU.S. Flu Season Ebbing, but Cases Still Widespread: CDCLab-Grown Blood Vessels Could Be Big Medical AdvanceClimate Change Will Aid Spread of Disease-Bearing MosquitoesSurgeons Perform First HIV-Positive Kidney Transplant From Living DonorAncestry Matters When Seeking Matched Bone Marrow DonorsBad Info May Be Scaring Patients Away From Heart-Healthy Statins
Questions and AnswersLinks
Related Topics

Diabetes

Psoriasis Meds Might Help Fight Heart Trouble, Too

HealthDay News
by -- Robert Preidt
Updated: Feb 5th 2019

new article illustration

TUESDAY, Feb. 5, 2019 (HealthDay News) -- Could the inflammation that drives psoriasis and other immune-linked illnesses be a major player in heart disease?

In a new study, certain psoriasis drugs appeared to help to keep arteries clear, suggesting such a link.

"Classically a heart attack is caused by one of five risk factors: diabetes, hypertension, high cholesterol, family history or smoking," explained study lead researcher Dr. Nehal Mehta.

"Our study presents evidence that there is a sixth factor, inflammation," she said.

Mehta heads the Laboratory of Inflammation and Cardiometabolic Diseases at the U.S. National Heart, Lung, and Blood Institute (NHLBI) in Bethesda, Md.

Another cardiologist agreed the study could open doors to new research.

"The future of cardiovascular prevention may require a cholesterol reduction medication and an anti-inflammatory medication," said Dr. Guy Mintz, who directs heart health at Northwell Health's Sandra Atlas Bass Heart Hospital in Manhasset, N.Y.

"These are exciting times in the area of cardiovascular prevention," said Mintz, who wasn't involved with the study.

The new study involved 121 patients who had moderate to severe psoriasis and qualified for anti-inflammatory medicines called biologic therapies. These injected medicines are also used by people with immune-linked conditions such as lupus or rheumatoid arthritis, and include drugs such as Cimzia, Enbrel, Humira, Orencia and Remicade, among others.

All of these medicines work by helping to suppress pro-inflammatory immune system activity.

All participants enrolled in the new study were at low risk of heart disease at the beginning of the research.

Over a year of follow-up, the use of biologic therapy was associated with an 8 percent reduction in coronary artery plaque, the researchers said.

Specifically, use of biologic drugs appeared linked with a slowed buildup of fatty plaques in arteries. These are the plaques that can restrict blood flow and cause heart attacks and stroke.

The findings suggest that immunotherapies that treat inflammatory conditions might also help cut heart disease risk, Mehta and his colleagues reported.

The study authors pointed to prior research that tied psoriasis to the early development of high-risk "soft" arterial plaques. Biologic therapy might cut plaque formation, even in patients without other heart disease risk factors such as high cholesterol, blood sugar and blood pressure, they said.

"This appears to be an anti-inflammatory effect," Mehta explained in an NHLBI news release. "In the absence of improvement in other cardiovascular risk factors, and without adding new cholesterol medications, patients' soft plaque still improved."

However, a cause-and-effect relationship isn't clear from this type of study, so "the next steps should be randomized, controlled trials," Mehta said.

Dr. Michele Green is a dermatologist who treats psoriasis patients at Lenox Hill Hospital in New York City. She wasn't involved in the new study, but said that "treatments with biologics indeed shows great promise in treating cardiovascular disease."

As for Mintz, he called the new research "exciting and important, because it highlights the importance of inflammation associated with psoriasis causing blockages in the arteries of the heart to progress.

"The best statin in the world can only lower cardiovascular events by approximately 40 percent," Mintz pointed out. "So the question arises, what causes the other 60 percent of cardiovascular events?"

The new research "supports the hypothesis that inflammation contributes to cardiovascular disease," he said. "Physicians need to become aware that inflammation should be considered in patient cardiovascular risk assessment."

The study appears online Feb. 5 in the journal Cardiovascular Research.

More information

The National Psoriasis Foundation offers more on biologic drugs.